BIO-TECHNE Corp
TECH· Nasdaq
TECHBIO-TECHNE Corp
Filed Aug 23, 2023 · 10-K · 54 days after period end · 0001558370-23-015226
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $301.32M | $288.23M | $259.03M | $175.83M |
| Net Income | $75.49M | $61.52M | $14.96M | $58.85M |
| EPS Diluted | — | — |
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
| — |
| $1.48 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Jun 30, 2023 · filed Aug 23, 2023 · 54 d after period end
